🔴 Wave Life Sciences is trading 5% down with no clear catalyst identified

Wave Life Sciences is trading at $3.28, down 5.20% during the October 12 session, with no clear company-specific catalyst identified.

• Available company news centers on the October 1 FDA-pathway update; no new October 12 catalyst surfaced.
• Broader indexes were mixed: the Nasdaq fell 0.49% and the S&P 500 fell 0.16%, which does not establish a broad-market cause.
• Trading volume or unusual activity was not verified, and the decline’s specific driver remains unclear.